Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             106 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests Belozertseva, I.V.
 2007
 17 Supplement 4 p. 172-179
8 p.
 artikel
2 Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive–compulsive disorder: A meta-analysis of the randomized controlled trials Skapinakis, Petros
 2007
 17 Supplement 4 p. 79-93
15 p.
 artikel
3 Author Index 2007
 17 Supplement 4 p. S95-S98
4 p.
 artikel
4 Calendar 2007
 17 Supplement 4 p. 78-
1 p.
 artikel
5 C.14.01 Neurobiological overview of attention- deficit/hyperactivity disorder Biederman, J.
 2007
 17 Supplement 4 p. S606-
1 p.
 artikel
6 C.20.01 New pharmacological tools in evaluation of antidepressant molecules Owens, M.J.
 2007
 17 Supplement 4 p. S610-
1 p.
 artikel
7 C.05.03 Rhythm hypotheses of mood and sleep disorders Hajak, G.
 2007
 17 Supplement 4 p. S600-
1 p.
 artikel
8 CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence Sher, Leo
 2007
 17 Supplement 4 p. 12-15
4 p.
 artikel
9 C.12.02 The interaction between the internal clock and antidepressant efficacy Racagni, G.
 2007
 17 Supplement 4 p. S605-
1 p.
 artikel
10 Desensitization of 5-HT1A autoreceptors induced by neonatal DSP-4 treatment Dąbrowska, Joanna
 2007
 17 Supplement 4 p. 129-137
9 p.
 artikel
11 Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects Ritsner, Michael
 2007
 17 Supplement 4 p. 358-365
8 p.
 artikel
12 ECNP Calendar of Events 2007
 17 Supplement 4 p. I-
1 p.
 artikel
13 E.01.01 Endophenotypes in schizophrenia: implications for diagnosis, treatment and etiological research Paunio, T.
 2007
 17 Supplement 4 p. S221-
1 p.
 artikel
14 Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating Schreiber, Rudy
 2007
 17 Supplement 4 p. 277-288
12 p.
 artikel
15 E.02.02 The management of bipolar disorder in the elderly Grunze, H.
 2007
 17 Supplement 4 p. S222-
1 p.
 artikel
16 P.3.a.016 Associations between negative symptoms, service use, and costs in patients with schizophrenia in five European countries Knapp, M.
 2007
 17 Supplement 4 p. S410-
1 p.
 artikel
17 P.6.a.007 Cognitive functioning in patients with fetal alcohol syndrome and fetal alcohol effect Przybylo, J.
 2007
 17 Supplement 4 p. S542-
1 p.
 artikel
18 P.3.a.002 Deficits in reward sensitivity and reversal learning in chronic schizophrenia during decision-making tasks Kim, Y.T.
 2007
 17 Supplement 4 p. S402-
1 p.
 artikel
19 P.8.a.006 Does quetiapine improve neurocognitive functions in borderline personality? Van den Eynde, F.
 2007
 17 Supplement 4 p. S583-
1 p.
 artikel
20 P.4.a.014 DSM-V recategorisation of depression and anxiety disorders: ALSPAC cohort evidence showing factor stability over time Davies, S.J.C
 2007
 17 Supplement 4 p. S508-
1 p.
 artikel
21 P.2.a.025 Exploratory study of actigraphic and psychometric measures in depressed patients treated with agomelatine or sertraline Wulff, K.
 2007
 17 Supplement 4 p. S326-
1 p.
 artikel
22 P.8.a.023 HLA typing, CSF hypocretin-1 and MSLT for the diagnosis of narcolepsy and idiopathic hypersomnia in 121 Korean patients Hong, S.C.
 2007
 17 Supplement 4 p. S593-
1 p.
 artikel
23 P.8.a.009 Malondialdehyde as a biological marker of acute schizophrenia Diaz-Mesa, E.
 2007
 17 Supplement 4 p. S584-S585
2 p.
 artikel
24 P.2.a.028 Monoamine metabolites level in CSF are related to the 5-HTT gene polymorphism in treatment-resistant depression Kishida, I.
 2007
 17 Supplement 4 p. S328-
1 p.
 artikel
25 P.4.a.011 Olanzapine in posttraumatic stress disorder (PTSD): efficacy in a double-blind, randomized, placebo-controlled, study Carey, P.
 2007
 17 Supplement 4 p. S506-
1 p.
 artikel
26 P.2.04 A rat model predicting sexual side effects of antidepressants Chan, J.S.W.
 2007
 17 Supplement 4 p. S42-S43
2 p.
 artikel
27 P.1.a.003 Serotonin transporter gene polymorphism associated with venlafaxine treatment response Choi, T.K.
 2007
 17 Supplement 4 p. S228-S229
2 p.
 artikel
28 P.1.08 Associations between plasma BDNF and CCK-4 challenge in healthy subjects Maron, E.
 2007
 17 Supplement 4 p. S8-S9
2 p.
 artikel
29 P.1.a.017 Synaptosomal-associated protein of 25kDa (SNAP-25) polymorphisms and cognitive dysfunctions in schizophrenic patients during an atypical antipsychotic treatment Spellmann, I.
 2007
 17 Supplement 4 p. S237-
1 p.
 artikel
30 P.6.a.004 The effect of naltrexone and acamprosate on cue-induced craving and fysiological cue-reactivity in alcoholics Ooteman, W.
 2007
 17 Supplement 4 p. S540-
1 p.
 artikel
31 P.7.a.004 The extent of pupillary fluctuations in the dark correlates with anxiety, depressive and autistic symptoms in ADHD Szab´o, K.
 2007
 17 Supplement 4 p. S568-S569
2 p.
 artikel
32 P.2.a.011 Tolerability and safety of escitalopram in randomised controlled trials in major depression and anxiety disorders Baldwin, D.
 2007
 17 Supplement 4 p. S317-S318
2 p.
 artikel
33 P.4.b.012 Chronic diazepam treatment and reactivity of 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter Zangrossi Junior, H.
 2007
 17 Supplement 4 p. S516-S517
2 p.
 artikel
34 P.3.b.002 Does COMT polymorphism influence cognitive function in first episode psychosis? Aas, M.
 2007
 17 Supplement 4 p. S418-
1 p.
 artikel
35 P.2.b.007 Effects of chronic mild stress on depression-like behavior and antioxidant status in mice. Brocardo, P.S.
 2007
 17 Supplement 4 p. S336-
1 p.
 artikel
36 P.5.b.001 The failure of the G1/S transition checkpoint in peripheral lymphocytes culture from patients with Alzheimer's disease Song, M.
 2007
 17 Supplement 4 p. S532-
1 p.
 artikel
37 P.3.b.005 The role of dopamine and glutamate in superstition: an investigation using ketamine Klaassen, E.
 2007
 17 Supplement 4 p. S420-
1 p.
 artikel
38 P.1.c.026 Acetylcholinesterase protection by donepezil against organophosphate toxicity Zivin, M.
 2007
 17 Supplement 4 p. S256-S257
2 p.
 artikel
39 P.3.c.022 A new validated method for classifying psychotic patients regarding treatment response: CANSEPT Alenius, M.
 2007
 17 Supplement 4 p. S436-S437
2 p.
 artikel
40 P.6.c.003 Aripirazole for methamphetamine dependence; a phase I human safety study Elkashef, A.
 2007
 17 Supplement 4 p. S550-S551
2 p.
 artikel
41 P.3.c.080 Association between −759C/T and −697G/C polymorphisms of the 5HT2C receptor gene and olanzapine-induced weight gain Godlewska, B.
 2007
 17 Supplement 4 p. S470-S471
2 p.
 artikel
42 P.2.c.016 Comparative efficacy of escitalopram and duloxetine in the acute treatment of major depressive disorder Bose, A.
 2007
 17 Supplement 4 p. S349-S350
2 p.
 artikel
43 P.3.c.025 Drug interactions between aripiprazole and haloperidol: double blind placebo controlled study Shim, J.C.
 2007
 17 Supplement 4 p. S438-S439
2 p.
 artikel
44 P.1.c.023 Effects of a glucocorticoid receptor antagonist and an SSRI on 5-HT transporter binding and 5-HT1A receptor mRNA Johnson, D.A.
 2007
 17 Supplement 4 p. S255-
1 p.
 artikel
45 P.1.c.040 Electrophysiological and behavioral profile of a GABAA alpha5 subtype-functionally selective negative modulator Savic, M.M.
 2007
 17 Supplement 4 p. S265-
1 p.
 artikel
46 P.2.c.019 Korean medication algorithm for depressive disorder 2006(IV): treatment strategy according to the clincal situations Jeon, H.T.
 2007
 17 Supplement 4 p. S351-S352
2 p.
 artikel
47 P.1.c.009 Memory impairment induced by chronic sodium fluoride intake Andreatini, R.
 2007
 17 Supplement 4 p. S247-
1 p.
 artikel
48 P.3.c.083 Metabolic safety of bifeprunox in treatment of acute or stable patients with schizophrenia Newcomer, J.
 2007
 17 Supplement 4 p. S472-S473
2 p.
 artikel
49 P.3.c.066 Neurocognition and attitudes to medication in risperidone long-acting injectable Penad´es, R.
 2007
 17 Supplement 4 p. S462-S463
2 p.
 artikel
50 P.3.c.008 Patterns of prescription and effectiveness in a European cohort of acutely agitated schizophrenic or bipolar patients Bonnett-Perrin, E.
 2007
 17 Supplement 4 p. S428-
1 p.
 artikel
51 P.3.c.039 Real world antipsychotic prescribing patterns for schizophrenia treatment across Europe Locklear, J.
 2007
 17 Supplement 4 p. S447-
1 p.
 artikel
52 P.3.c.019 Reduced supramarginal alpha power after 4-weeks antipsychotic treatment in schizophrenic patients Shin, C.J.
 2007
 17 Supplement 4 p. S434-S435
2 p.
 artikel
53 P.3.c.056 Short-term olanzapine-induced weight gain is not associated with the −2548G/A polymorphism of the leptin gene Ciwoniuk, M.
 2007
 17 Supplement 4 p. S456-S457
2 p.
 artikel
54 P.2.c.006 Survival rates of maintenance treatment with venlafaxine extended-release in patients with somatic symptoms Seo, H.J.
 2007
 17 Supplement 4 p. S344-
1 p.
 artikel
55 P.2.c.033 Venlafaxine-treatment in female patients with depressive disorder in menopausal period Filovska, V.
 2007
 17 Supplement 4 p. S359-S360
2 p.
 artikel
56 P.1.d.001 Comparison of effects of different types of environmental enrichment on behaviour of C57/BL mice in plus-maze-test Pokk, P.
 2007
 17 Supplement 4 p. S273-S274
2 p.
 artikel
57 P.1.d.004 Deficits in attentional set-shifting in rats following sub-chronic phencyclidine (PCP) administration, effect of gender McLean, S.L.
 2007
 17 Supplement 4 p. S275-
1 p.
 artikel
58 P.3.d.013 Impact of chronic antipsychotic treatments on hypersensitivity to MK-801 in a neurodevelopmental model of schizophrenia Le Pen, G.
 2007
 17 Supplement 4 p. S480-S481
2 p.
 artikel
59 P.2.d.010 In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha2-adrenergic and 5-HT1A receptors Berrocoso, E.
 2007
 17 Supplement 4 p. S367-S368
2 p.
 artikel
60 P.7.d.003 Prevalence of obsessive compulsive disorder among female secondary schools in Cairo Soltan, M.
 2007
 17 Supplement 4 p. S577-
1 p.
 artikel
61 P.2.d.013 The intensity dependence of auditory Event Related Potential (ERP) components in unmedicated major depression and healthy controls Linka, T.
 2007
 17 Supplement 4 p. S369-
1 p.
 artikel
62 P.2.e.001 Cluster analysis of depressive symptoms in bipolar type I patients Macedo-Soares, M.B.
 2007
 17 Supplement 4 p. S377-
1 p.
 artikel
63 P.3.e.004 Comorbid obsessive-compulsive disorder in patients with schizophrenia treated with atypical antipsychtics Kang, M.H.
 2007
 17 Supplement 4 p. S489-
1 p.
 artikel
64 P.4.e.004 Effect of mirtazapine on memory function of patients with posttraumatic stress disorder Chung, M.
 2007
 17 Supplement 4 p. S522-
1 p.
 artikel
65 P.1.e.015 Event Related fMRI of successful implicit encoding of negative and neutral words in Major Depressive Disorder van der Wee, N.
 2007
 17 Supplement 4 p. S289-
1 p.
 artikel
66 P.2.003 Effects of modern antidepressants with different mode of action on cardiovascular parameters in patients with major depressive disorder and response to treatment Zeugmann, S.
 2007
 17 Supplement 4 p. S155-
1 p.
 artikel
67 P.2.21 Effects of “pulse therapy” with imipramine in the chronic mild stress model in rats Kusmider, M.
 2007
 17 Supplement 4 p. S55-S56
2 p.
 artikel
68 P.6.e.002 Impact of attention deficit hyperactivity disorder comorbidity in substance use disorders Danki Erken, D.
 2007
 17 Supplement 4 p. S559-
1 p.
 artikel
69 P.2.07 Environmental stimulation reduces the rewarding and activating effects of cocaine El Rawas, R.
 2007
 17 Supplement 4 p. S45-
1 p.
 artikel
70 P.6.e.005 Relationship between personality dimensions, substance misuse and repetition of deliberate self harm Sinclair, J.
 2007
 17 Supplement 4 p. S560-S561
2 p.
 artikel
71 P.3.e.007 Specificity of autobiographical memory in a group of stabilized schizophrenic patients Lecompte, D.
 2007
 17 Supplement 4 p. S490-S491
2 p.
 artikel
72 P.2.e.018 The effect of olanzapine monotherapy on subjective estimates of sleep in acute mania Yoon, B.
 2007
 17 Supplement 4 p. S386-S387
2 p.
 artikel
73 P.1.e.005 Treatment effect of modafinil on the attention-related brain circuit in major depression using H215O PET Seok, J.H.
 2007
 17 Supplement 4 p. S283-
1 p.
 artikel
74 P.1.f.003 Are schizophrenia and bipolar I disorder seperate disease entities? A study with neurocognitive performance Lee, Y.S.
 2007
 17 Supplement 4 p. S297-S298
2 p.
 artikel
75 P.1.f.006 Cognitive versus emotional decision-making in healthy subjects using the Game of Dice Task and the Iowa Gambling Task Jeong, S.
 2007
 17 Supplement 4 p. S299-S300
2 p.
 artikel
76 P.3.f.003 Illness activity or medical history – what is most important for family burden in schizophrenia? The impact of remission Hjärthag, F.
 2007
 17 Supplement 4 p. S498-
1 p.
 artikel
77 P.3.f.006 Increased TNF-alpha with concomitant reduced IL-4 concentrations in patients with acute exacerbation of schizophrenia O'Brien, S.M.
 2007
 17 Supplement 4 p. S500-
1 p.
 artikel
78 P.2.g.007 Biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) Leuchter, A.F.
 2007
 17 Supplement 4 p. S394-S395
2 p.
 artikel
79 P.3.16 Gender differences in the 5-HT1A receptor and serotonin transporter in the human brain: a PET study Jovanovic, H.
 2007
 17 Supplement 4 p. S82-S83
2 p.
 artikel
80 P.1.g.010 Regulation of neuronal growth cone morphology by prolyl oligopeptidase revealed by manipulation of gene expression Di Daniel, E.
 2007
 17 Supplement 4 p. S308-
1 p.
 artikel
81 P.2.g.004 Repetitive transcranial magnetic stimulation for depression: a randomised controlled trial with 4-month follow-up McLoughlin, D.M.
 2007
 17 Supplement 4 p. S392-S393
2 p.
 artikel
82 P.2.g.010 Trazodone in the treatment of fibromyalgia: an interim analysis of a 12-week study Calandre, E.
 2007
 17 Supplement 4 p. S396-
1 p.
 artikel
83 P.2.h.002 Paroxetine effects on emotions: a 4-week randomized placebo-controlled pilot study in psychologists and psychiatrists Cass´e-Perrot, C.
 2007
 17 Supplement 4 p. S398-S399
2 p.
 artikel
84 P.1.34 Involvement of GABAergic interneurons on the modulation of pyramidal neuron activity in PFC by 8-OH-DPAT Lladó, L.
 2007
 17 Supplement 4 p. S30-S31
2 p.
 artikel
85 P.4.02 Localized gray matter deficits in adolescents with first-episode psychosis Janssen, J.
 2007
 17 Supplement 4 p. S92-S93
2 p.
 artikel
86 P.1.20 Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate Pillolla, G.
 2007
 17 Supplement 4 p. S18-
1 p.
 artikel
87 P.3.02 Metabolic side effects with second generation antipsychotics in antipsychotic-naive adolescents Fraguas, D.
 2007
 17 Supplement 4 p. S71-
1 p.
 artikel
88 P.1.17 Progesterone induced-changes in gene expression of delta subunit GABAA receptor in rat hippocampal neurons in culture Mostallino, M.C.
 2007
 17 Supplement 4 p. S15-S16
2 p.
 artikel
89 P.5.001 Some clinical peculiarities of the psychotic disorders in Alzheimer's disease Arnaudova, M.
 2007
 17 Supplement 4 p. S163-S164
2 p.
 artikel
90 P.1.009 The objectification of the types of the stability of the circadian rhythms of mood and vigor Madjirova, N.
 2007
 17 Supplement 4 p. S153-
1 p.
 artikel
91 S.22.01 Brain changes during the development of psychosis Pantelis, C.
 2007
 17 Supplement 4 p. S209-
1 p.
 artikel
92 S.15.03 Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depression Brunello, N.
 2007
 17 Supplement 4 p. S198-
1 p.
 artikel
93 S.01.05 Depression in adolescents: how to treat it Fegert, J.M.
 2007
 17 Supplement 4 p. S176-
1 p.
 artikel
94 S.1.1 Epigenetic mechanisms in stress-related learning and memory Reul, J.M.H.M.
 2007
 17 Supplement 4 p. S1-S2
2 p.
 artikel
95 S.18.03 European epidemiology of cannabis use in adolescents: determinants and risk factors Choquet, M.
 2007
 17 Supplement 4 p. S203-
1 p.
 artikel
96 Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents Hillegers, Manon H.J.
 2007
 17 Supplement 4 p. 394-399
6 p.
 artikel
97 S.01.02 Neurobiological/neuroendocrine correlates and predictors of outcome of conduct disorder van Goozen, S.H.M.
 2007
 17 Supplement 4 p. S175-
1 p.
 artikel
98 Social isolation stress and neuroactive steroids Serra, M.
 2007
 17 Supplement 4 p. 1-11
11 p.
 artikel
99 S.25.03 Predicting the effect of different anti-craving drugs on relapse Kiefer, F.
 2007
 17 Supplement 4 p. S214-S215
2 p.
 artikel
100 S.03.03 Prediction and prevention of postnatal depression Bloch, M.
 2007
 17 Supplement 4 p. S140-
1 p.
 artikel
101 S.09.05 Psycho education and cognitive remediation of bipolar disorder Torrent, C.
 2007
 17 Supplement 4 p. S191-
1 p.
 artikel
102 S.04.05 Regulation of post synaptic calcium influx in hippocampal CA1 pyramidal neurons via extracellular carbonic anhydrase Fedirko, N.
 2007
 17 Supplement 4 p. S181-
1 p.
 artikel
103 S.01.03 The complex relationship between migraine and psychiatry Oedegaard, K.J.
 2007
 17 Supplement 4 p. S133-S134
2 p.
 artikel
104 S.14.05 The Edinburgh high risk study Johnstone, E.
 2007
 17 Supplement 4 p. S196-S197
2 p.
 artikel
105 S.21.02 Treatment-resistant generalized anxiety disorder Baldwin, D.
 2007
 17 Supplement 4 p. S208-
1 p.
 artikel
106 The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs O'Leary, Olivia F.
 2007
 17 Supplement 4 p. 215-226
12 p.
 artikel
                             106 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland